Literature DB >> 26137053

Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells.

Muliang Ding1, Jianzhong Hu1, Jiangdong Ni2, Zhonghui Zheng2, Deye Song2, Junjie Wang2.   

Abstract

Osteosarcoma (OS), the most common malignant bone tumor, occurs mainly in adolescents and young adults, with a morbidity of ∼5 cases per million. The expression levels of microRNAs (miRNAs) as tumor suppressors were recently found to be downregulated in OS. Certain alterations of miRNAs and the possible mechanisms through which miRNAs affect cell proliferation and migration in OS were recently found to be correlated with methylation epigenetic mechanisms. In this study, it was demonstrated that, due to hypermethylation, the expression level of miRNA-142 (miR-142) was significantly downregulated in OS tissues and cells compared with that in control samples. The present study demonstrated an increased expression of miR-142 in Saos-2 and MG63 cells treated with demethylation agents, suggesting that the effect of such agents on cell growth, inhibition of invasion and cell cycle retardation may be mediated by miR-142 in OS.

Entities:  

Keywords:  methylation; microRNA; osteosarcoma; tumor suppressor

Year:  2015        PMID: 26137053      PMCID: PMC4467365          DOI: 10.3892/ol.2015.3036

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma.

Authors:  Daniel Baumhoer; Stephanie Zillmer; Kristian Unger; Michael Rosemann; Michael J Atkinson; Martin Irmler; Johannes Beckers; Heide Siggelkow; Irene von Luettichau; Gernot Jundt; Jan Smida; Michaela Nathrath
Journal:  Cancer Genet       Date:  2012-05

2.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Authors:  Mattia Boeri; Carla Verri; Davide Conte; Luca Roz; Piergiorgio Modena; Federica Facchinetti; Elisa Calabrò; Carlo M Croce; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

3.  MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Authors:  Pingyu Zhang; Katelynn Bill; Juehui Liu; Eric Young; Tingsheng Peng; Svetlana Bolshakov; Aviad Hoffman; Yechun Song; Elizabeth G Demicco; Dolores Lopez Terrada; Chad J Creighton; Matthew L Anderson; Alexander J Lazar; George G Calin; Raphael E Pollock; Dina Lev
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

4.  miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Authors:  Kevin B Jones; Zaidoun Salah; Sara Del Mare; Marco Galasso; Eugenio Gaudio; Gerard J Nuovo; Francesca Lovat; Kimberly LeBlanc; Jeff Palatini; R Lor Randall; Stefano Volinia; Gary S Stein; Carlo M Croce; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

5.  MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.

Authors:  Zhe Lei; Guili Xu; Longqiang Wang; Haiping Yang; Xia Liu; Jun Zhao; Hong-Tao Zhang
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

6.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

7.  MicroRNA Involvement in Osteosarcoma.

Authors:  Eisuke Kobayashi; Francis J Hornicek; Zhenfeng Duan
Journal:  Sarcoma       Date:  2012-04-03

Review 8.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

9.  Identification of Differentially Expressed MicroRNAs in Osteosarcoma.

Authors:  Rishi R Lulla; Fabricio F Costa; Jared M Bischof; Pauline M Chou; Maria de F Bonaldo; Elio F Vanin; Marcelo B Soares
Journal:  Sarcoma       Date:  2011-07-18

10.  Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.

Authors:  Ute Bissels; Stefan Wild; Stefan Tomiuk; Markus Hafner; Hartmut Scheel; Aleksandra Mihailovic; Yeong-Hoon Choi; Thomas Tuschl; Andreas Bosio
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

View more
  8 in total

1.  microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Authors:  Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  Loss-of-function of miR-142 by hypermethylation promotes TGF-β-mediated tumour growth and metastasis in hepatocellular carcinoma.

Authors:  Qiangfeng Yu; Leyang Xiang; Libo Yin; Xincheng Liu; Dinghua Yang; Jianyin Zhou
Journal:  Cell Prolif       Date:  2017-09-30       Impact factor: 6.831

4.  MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.

Authors:  Ziqiang Zhu; Jinshan Tang; Jianqiang Wang; Gang Duan; Lei Zhou; Xiaoqing Zhou
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

5.  Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.

Authors:  Fang Su; Jun Zhao; Shukui Qin; Rui Wang; Yumei Li; Qiang Wang; Yi Tan; Hao Jin; Fangquan Zhu; Yurong Ou; Zenong Cheng; Wen Su; Fuyou Zhao; Yan Yang; Zhengguang Zhou; Jiyue Zheng; Yawei Li; Zhongwen Li; Qiong Wu
Journal:  Oncotarget       Date:  2017-04-04

6.  Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.

Authors:  Kaniz Fatema; Zachary Larson; Jared Barrott
Journal:  Biocell       Date:  2022-06-13       Impact factor: 1.110

7.  miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb.

Authors:  Yan-Fang Gao; Qiu-Jie Zhang; Zhuang Yu; Shi-Hai Liu; Jun Liang
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

Review 8.  DNA methylation of noncoding RNAs: new insights into osteogenesis and common bone diseases.

Authors:  Liyuan Yu; Kai Xia; Xiao Cen; Xinqi Huang; Wentian Sun; Zhihe Zhao; Jun Liu
Journal:  Stem Cell Res Ther       Date:  2020-03-06       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.